BioCentury
ARTICLE | Company News

Express Scripts' Miller says HCV deals will save billions

January 28, 2015 2:32 AM UTC

Steve Miller, SVP and CMO of Express Scripts Holding Co. (NASDAQ:ESRX), wrote in a AbbVie Inc. (NYSE:ABBV) covering HCV treatment Viekira Pak will save its clients "more than $1 billion this year" on HCV treatments.

Miller said the "industry-wide ripple effect" of its decision will save the U.S. healthcare system more than $4 billion in 2015. Several PBMs and payers have reached agreements with AbbVie and Gilead Sciences Inc. (NASDAQ:GILD), which markets its Harvoni ledipasvir/ sofosbuvir and Sovaldi sofosbuvir, in which the drugmakers provide discounts for their HCV treatments in exchange for exclusive or preferred formulary status. ...